Nocardiosis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}


==Overview==
==Medical Therapy==
==Medical Therapy==
Nocardiosis requires at least 6 months of treatment, preferably with [[co-trimoxazole]] or high doses of [[sulfonamide]]s. In patients who don’t respond to sulfonamide treatment, other drugs, such as [[ampicillin]], [[erythromycin]], or [[minocycline]], may be added. Treatment also includes surgical drainage of [[abscess]]es and excision of necrotic tissue. The acute phase requires complete bed rest; as the patient improves, activity can increase. A new combination drug therapy ([[sulfonamide]], [[ceftriaxone]], and [[amikacin]]) has also shown promise.
Nocardiosis requires at least 6 months of treatment, preferably with [[co-trimoxazole]] or high doses of [[sulfonamide]]s. In patients who don’t respond to sulfonamide treatment, other drugs, such as [[ampicillin]], [[erythromycin]], or [[minocycline]], may be added. Treatment also includes surgical drainage of [[abscess]]es and excision of necrotic tissue. The acute phase requires complete bed rest; as the patient improves, activity can increase. A new combination drug therapy ([[sulfonamide]], [[ceftriaxone]], and [[amikacin]]) has also shown promise.

Revision as of 19:45, 10 December 2012

Nocardiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Nocardiosis from other Diseases

Epidemiology and Demographics

Causes

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nocardiosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nocardiosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nocardiosis medical therapy

CDC on Nocardiosis medical therapy

Nocardiosis medical therapy in the news

Blogs on Nocardiosis medical therapy

Directions to Hospitals Treating Nocardiosis

Risk calculators and risk factors for Nocardiosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Nocardiosis requires at least 6 months of treatment, preferably with co-trimoxazole or high doses of sulfonamides. In patients who don’t respond to sulfonamide treatment, other drugs, such as ampicillin, erythromycin, or minocycline, may be added. Treatment also includes surgical drainage of abscesses and excision of necrotic tissue. The acute phase requires complete bed rest; as the patient improves, activity can increase. A new combination drug therapy (sulfonamide, ceftriaxone, and amikacin) has also shown promise.

References

Template:WH Template:WS